ScholarWorks@Hanyang University: Browsing ScholarWorks

Browsing by Miranda, PedroAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Sort by: In order: Results/Page Authors/Record:

Showing results 1 to 12 of 12

SCISCIESCOPUS

A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study Go to Link

Park, Won; Hrycaj, Pawel; Jeka, Slawomir; Kovalenko, Volodymyr; Lysenko, Grygorii; Miranda, Pedro; Mikazane, Helena; Gutierrez-Urena, Sergio; Lim, MieJin; Lee, Yeon-Ah, et al.

ArticleIssue Date2013CitationAnnals of the Rheumatic Diseases, v.72, no.10, pp 1605 - 1612PublisherBMJ Publishing Group

SCISCIESCOPUS

A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study Go to Link

Yoo, Dae Hyun; Hrycaj, Pawel; Miranda, Pedro; Ramiterre, Edgar; Piotrowski, Mariusz; Shevchuk, Sergii; Kovalenko, Volodymyr; Prodanovic, Nenad; Abello-Banfi, Mauricio; Gutierrez-Urena, Sergio, et al.

ArticleIssue Date2013CitationAnnals of the Rheumatic Diseases, v.72, no.10, pp 1613 - 1620PublisherBMJ Publishing Group

SCISCIESCOPUS

Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations Go to Link

Kim-Howard, Xana; Sun, Celi; Molineros, Julio E.; Maiti, Amit K.; Chandru, Hema; Adler, Adam; Wiley, Graham B.; Kaufman, Kenneth M.; Kottyan, Leah; Guthridge, Joel M., et al.

ArticleIssue Date2014CitationHuman Molecular Genetics, v.23, no.6, pp 1656 - 1668PublisherOxford University Press

SCIESCOPUS

Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial Go to Link open access

Park, Won; Bozic-Majstorovic, Ljubinka; Milakovic, Dragana; Berrocal Kasay, Alfredo; Chalouhi El-Khouri, Elias; Irazoque-Palazuelos, Fedra; Cons Molina, Francisco Fidencio; Shesternya, Pavel; Miranda, Pedro; Medina-Rodriguez, Francisco G., et al.

ArticleIssue Date2018CitationMABS, v.10, no.6, pp.934 - 943PublisherTAYLOR & FRANCIS INC

Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks Go to Link

Yoo, Dae-Hyun; Majstorovic, Ljubinka Bozic; Berrocal Kasay, Alfredo; Chalouhi El-Khouri, Elias; Irazoque-Palazuelos, Fedra; Cons Molina, Francisco; Miranda, Pedro; Shesternya, Pavel; Medina-Rodriguez, Francisco G.; Wiland, Piotr, et al.

ConferenceIssue Date2016Citation2016 ACR/ARHP Annual MeetingPublisherWILEYPlaceUS

SCISCIESCOPUS

Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study Go to Link

Yoo, Dae Hyun; Prodanovic, Nenad; Jaworski, Janusz; Miranda, Pedro; Ramiterre, Edgar; Lanzon, Allan; Baranauskaite, Asta; Wiland, Piotr; Abud-Mendoza, Carlos; Oparanov, Boycho, et al.

ArticleIssue Date2017CitationAnnals of the Rheumatic Diseases, v.76, no.2, pp 355 - 363PublisherBMJ Publishing Group

Efficacy and Safety of Rituximab Biosimilar, CT-P10, after a Single Switch from Innovator Rituximabs in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 72 Weeks Go to Link

Shim, Seung-Cheol; Majstorovic, Ljubinka Bozic; Berrocal Kasay, Alfredo; Chalouhi El-Khouri, Elias; Irazoque-Palazuelos, Fedra; Cons Molina, Francisco; Medina-Rodriguez, Francisco G.; Miranda, Pedro; Shesternya, Pavel; Chavez Corrales, Jose, et al.

ConferenceIssue Date2017Citation2017 ACR/ARHP Annual MeetingPublisherWILEYPlaceUS

SCISCIESCOPUS

Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study Go to Link

Park, Won; Yoo, Dae Hyun; Miranda, Pedro; Brzosko, Marek; Wiland, Piotr; Gutierrez-Urena, Sergio; Mikazane, Helena; Lee, Yeon-Ah; Smiyan, Svitlana; Lim, Mie-Jin, et al.

ArticleIssue Date2017CitationAnnals of the Rheumatic Diseases, v.76, no.2, pp 346 - 354PublisherBMJ Publishing Group

SCIESCOPUS

Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial Go to Link open access

Shim, Seung Cheol; Božić-Majstorović, Ljubinka; Kasay, Alfredo Berrocal; El-Khouri, Elias Chalouhi; Irazoque-Palazuelos, Fedra; Molina, Francisco Fidencio Cons; Medina-Rodriguez, Francisco G.; Miranda, Pedro; Shesternya, Pavel; Chavez-Corrales, Jose, et al.

ArticleIssue Date2019CitationRHEUMATOLOGY, v.58, no.12, pp.2193 - 2202PublisherOXFORD UNIV PRESS

Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized Placebo-Controlled Trial Of Golimumab In Patients With Active Rheumatoid Arthritis Despite Prior Treatment With Methotrexate Go to Link

Keystone, Edward; Genovese, Mark C.; Hall, Stephen; Miranda, Pedro; Bae, Sang-Cheol; Han, Chenglong; Gathany, Timothy A.; Zhou, Yiying; Xu, Stephen; Hsia, Elizabeth C.

ConferenceIssue Date2013Citation77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, pp.S597 - S598PublisherWILEY-BLACKWELLPlaceUS; San Diego, CA

SCISCIESCOPUS

Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture Go to Link

Alarcon-Riquelme, Marta E.; Ziegler, Julie T.; Molineros, Julio; Howard, Timothy D.; Moreno-Estrada, Andres; Sanchez-Rodriguez, Elena; Ainsworth, Hannah C.; Ortiz-Tello, Patricia; Comeau, Mary E.; Rasmussen, Astrid, et al.

ArticleIssue Date2016CitationArthritis and Rheumatology, v.68, no.4, pp 932 - 943PublisherJohn Wiley and Sons Ltd

Pharmacokinetics and Safety of Three Formulations of Rituximab (CT-P10, US-sourced Innovator Rituximab and EU-sourced Innovator Rituximab) in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks Go to Link

Suh, Chang-Hee; Berrocal Kasay, Alfredo; Chalouhi El-Khouri, Elias; Miranda, Pedro; Majstorovic, Ljubinka Bozic; Jeka, Slawomir; Hrycaj, Pawel; Rekalov, Dmytro; Wiland, Piotr; Krause, Andreas, et al.

ConferenceIssue Date2016Citation2016 ACR/ARHP Annual MeetingPublisherWILEYPlaceUS

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Browsing by Miranda, PedroAuthor

BROWSE